Figure 6.
Reduced urinary frequency and urgency associated with lipo-BoNT treatment vs. placebo. The treatment-associated frequency reduction (compared to placebo) statistically significant at 4-weeks (p < 0.03). Adapted from [27].
Reduced urinary frequency and urgency associated with lipo-BoNT treatment vs. placebo. The treatment-associated frequency reduction (compared to placebo) statistically significant at 4-weeks (p < 0.03). Adapted from [27].